Table 1.
S.No | Drugs/therapy | Cancer therapy | Targets | Pharmacological action | Limitation | Reference |
---|---|---|---|---|---|---|
1. | Doxorubicin | Chemotherapy | Breast cancer, Lung cancer, Hodgkin lymphoma, Non-Hodgkin lymphoma, leukemia, Ovarian cancer, sarcomas | Interacts with DNA | Cardiotoxicity | [227] |
Inhibits topoisomerase | ||||||
Disrupts DNA and RNA synthesis | The risk of cumulative toxicity increases with repeated doses, potentially impacting the long-term use of the drug | |||||
Induces cell death | ||||||
2. | Cisplatin | Testicular, bladder, ovarian, and head-neck cancers | Forms DNA cross-links | Nephrotoxicity | [228, 229] | |
Inhibits DNA replication and transcription | ||||||
Neurotoxicity | ||||||
Promotes cell death | ||||||
Causes DNA damage | ||||||
3. | Paclitaxel and Docetaxel | Breast, ovarian, lung, and prostate cancers | Stabilizes microtubules | Neutropenia (a decrease in white blood cells), increasing the risk of infections | [230, 231] | |
Inhibits cell division | ||||||
Induces cell death | ||||||
Hypersensitivity reactions | ||||||
4. | Methotrexate | Leukemia, lymphomas, breast, and lung cancers | Inhibits dihydrofolate reductase | Suppress the bone marrow, leading to myelosuppression and an increased risk of infections, anemia, and bleeding | [232] | |
High doses of methotrexate can cause renal toxicity | ||||||
Disrupts nucleic acid and protein synthesis | ||||||
Reduces thymidine production | ||||||
5. | 5-Fluorouracil | Colorectal, breast, stomach, and pancreatic cancers | Inhibits Thymidylate Synthase | Cardiotoxicity | [233] | |
Disrupts Thymidine Synthesis | Gastrointestinal toxicity | |||||
Inhibits DNA Synthesis Causes Cell Death | ||||||
6. | X-ray | Radiation Therapy | Bone Cancer, breast cancer, gastrointestinal cancers, head and neck cancer | They interact with tissues and produce images based on differential absorption | X-rays are non-specific and can affect both cancerous and healthy tissues, leading to potential damage to surrounding normal structures | [234] |
7. | Gamma ray | Breast cancer, lung cancer, gastrointestinal cancer, head and neck cancer, brain cancer, prostate cancer, Gynecological Cancers, Bone Metastases | Directed toward damaging DNA in targeted cells | Gamma rays penetrate tissues deeply, they may still cause damage to normal tissues along their path | [235] | |
8. | Proton ray | Pediatric Cancers, Brain and Spinal Cord Tumors, Eye Tumors (Ocular Melanomas), head and neck cancer, thoracic cancer, Prostate Cancer, Bone and Soft Tissue Sarcomas | Protons deposit their energy in a controlled manner within the targeted tissues, damaging the DNA of cancer cells and inhibiting their ability to divide and grow | Limited accessibility | [236] | |
9. | Electron beams | Skin cancer, breast cancer, Extremity Sarcomas, head and neck cancer, Keloids and Hypertrophic Scars, Superficial Lymphomas, Eye Tumors | Electron beams interact with tissues to deposit energy. Their use in therapy is aimed at damaging cancer cells and inhibiting their growth | Electron beams are effective for treating superficial tumors but may not penetrate deeply enough for certain deeper-seated tumors | [237] | |
10. | Curative surgery | Surgery | Breast cancer, colorectal cancer, lung cancer, prostate cancer, thyroid cancer, ovarian cancer, testicular cancer, melanoma, bladder cancer, gastro cancer | Remove the entire tumor or cancerous tissue | Curative surgery may not be feasible if the cancer has spread extensively or if the tumor is located in a critical or inaccessible area | [238] |
11. | Debulking surgery | Ovarian, pancreatic, and colorectal cancers | Debulking surgery involves the removal of a portion of the tumor when complete removal is not feasible. The goal is to reduce the size of the tumor, alleviate symptoms, and enhance the effectiveness of other treatments | Debulking surgery may not eliminate all cancer cells, and complete removal may not be achievable in some cases | [239] | |
12. | Palliative surgery | Palliative surgery used for advanced cancers, easing symptoms, improving comfort | Palliative surgery focuses on alleviating symptoms and improving the quality of life for patients with advanced or incurable cancer. It may involve the removal of a tumor or part of it to reduce pain or obstruction | Palliative surgery does not aim to cure cancer but focuses on symptom relief. It may not be suitable for all patients, especially those with a poor overall health status | [240] | |
13. | Diagnostic surgery | Cancer biopsy and accurate cancer staging | Diagnostic surgery is performed to obtain a sample of tissue (biopsy) for laboratory analysis, confirming the presence of cancer and determining its characteristics | Diagnostic surgery involves some risk, and there is a possibility of complications. It may not be suitable for all patients, particularly those with significant health issues | [241] | |
14. | Staging and lymph node removal | Staging surgery used for accurate cancer staging, often involves lymph nodes | Staging surgery helps determine the extent of cancer spread, and it often involves the removal and examination of nearby lymph nodes to assess whether the cancer has spread | Staging surgery may not detect microscopic metastases, and the removal of lymph nodes may cause complications such as lymphedema | [242] | |
15. | Reconstructive surgery | Breast cancer | Reconstructive surgery is performed to restore the appearance or function of an area after cancer removal | Reconstructive surgery may have aesthetic and functional limitations, and it may not be suitable for all patients, especially those with certain health conditions | [243] | |
16. | Minimally invasive surgery | Gastrointestinal Cancers, Gynecological Cancers, Thoracic cancer, prostate cancer, head and neck cancer, kidney cancer, liver cancer, and pancreatic cancer | Minimally invasive surgery uses small incisions and specialized instruments to perform procedures with less impact on surrounding tissues | Minimally invasive surgery may not be suitable for complex or extensive procedures, and it may have a steeper learning curve for surgeons | [244] |